Healthcare - Biotechnology - NASDAQ - US
$ 0.5
-9.26 %
$ 6.21 M
Market Cap
-0.3
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
1421.44%
EBIT
Estimate
--107.23%
Net Income
Estimate
59.25%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
ABVC BioPharma, Inc.
ABVC has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ABVC
EBIT FORECAST
EBIT Forecast Chart ABVC
NET INCOME FORECAST
Net Income Chart ABVC